dalteparin has been researched along with Injuries, Leg in 16 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The overall deep vein thrombosis (DVT) rate in group 1 was 3." | 1.31 | Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer. ( Hafner, G; Hansen, M; Mayer, A; Peetz, D; Prellwitz, W; Rippin, G; Rommens, PM, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bruntink, MM | 1 |
| Groutars, YME | 1 |
| Schipper, IB | 1 |
| Breederveld, RS | 1 |
| Tuinebreijer, WE | 1 |
| Derksen, RJ | 1 |
| Haentjens, P | 1 |
| Peetz, D | 1 |
| Hafner, G | 1 |
| Hansen, M | 1 |
| Mayer, A | 1 |
| Rippin, G | 1 |
| Rommens, PM | 1 |
| Prellwitz, W | 1 |
| Mower, S | 1 |
| Thompson, S | 1 |
| Sems, SA | 1 |
| Levy, BA | 1 |
| Dajani, K | 1 |
| Herrera, DA | 1 |
| Templeman, DC | 1 |
| Szczesny, G | 1 |
| Deszczyński, J | 1 |
| Lassen, MR | 1 |
| Borris, LC | 1 |
| Nakov, RL | 1 |
| Doggrell, SA | 1 |
| Jersmann, HP | 1 |
| Murashige, N | 1 |
| Kami, M | 1 |
| Takaue, Y | 1 |
| Girard, P | 1 |
| Gehling, H | 1 |
| Giannadakis, K | 1 |
| Lefering, R | 1 |
| Hessmann, M | 1 |
| Achenbach, S | 1 |
| Gotzen, L | 1 |
| Menakaya, CU | 1 |
| Pennington, N | 1 |
| Muthukumar, N | 1 |
| Joel, J | 1 |
| Ramirez Jimenez, AJ | 1 |
| Shaw, CJ | 1 |
| Mohsen, A | 1 |
| Selby, R | 1 |
| Geerts, WH | 1 |
| Kreder, HJ | 1 |
| Crowther, MA | 1 |
| Kaus, L | 1 |
| Sealey, F | 1 |
| Little, MT | 1 |
| Goel, DP | 1 |
| Buckley, R | 1 |
| deVries, G | 1 |
| Abelseth, G | 1 |
| Ni, A | 1 |
| Gray, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylaxis of Venous Thromboembolism in Patients With a Nonsurgical Fracture of the Lower Extremity Immobilised in a Below-Knee Plaster Cast[NCT00881088] | Phase 2/Phase 3 | 669 participants (Anticipated) | Interventional | 2009-04-30 | Recruiting | ||
| A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients[NCT02774265] | Phase 3 | 329 participants (Actual) | Interventional | 2016-01-31 | Completed | ||
| Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort.[NCT01303523] | 1,627 participants (Actual) | Observational | 2010-12-31 | Completed | |||
| Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention[NCT00187408] | Phase 4 | 700 participants | Interventional | 2002-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
DVT and how the diagnosis was made will be recorded. The number of events in participants in each arm will be compared to evaluate efficacy. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 5 |
| VTE Prophylaxis With Aspirin 81mg BID | 9 |
Bases on imaging obtained for symptoms. (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 6 |
| VTE Prophylaxis With Aspirin 81mg BID | 2 |
Includes a greater than 2g/dL drop in hemoglobin, blood transfusion, hematoma evacuation, re-operation for a deep surgical site infection or minor procedure for bleeding and GI bleed (NCT02774265)
Timeframe: 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| VTE Prophylaxis With Enoxaparin 30mg BID | 52 |
| VTE Prophylaxis With Aspirin 81mg BID | 53 |
1 review available for dalteparin and Injuries, Leg
| Article | Year |
|---|---|
Reviparin as prophylaxis for thromboembolism after leg injury and hip replacement.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Heparin, Low-Molecular-Weight; | 2003 |
7 trials available for dalteparin and Injuries, Leg
| Article | Year |
|---|---|
Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below-knee plaster cast (PROTECT): A randomised controlled trial.
Topics: Adult; Anticoagulants; Casts, Surgical; Female; Fondaparinux; Humans; Immobilization; Leg Injuries; | 2017 |
Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium)
Topics: Aged; Anticoagulants; Drug Administration Schedule; Female; Hip Fractures; Humans; Leg Injuries; Mal | 1996 |
[The frequency of peri- and postoperative bleeding after prophylactic treatment with enoxapirin in patients with post-traumatic deep vein thrombosis].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Transfusion; Enoxaparin; Female; Humans; Leg I | 2000 |
Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.
Topics: Achilles Tendon; Adult; Anticoagulants; Braces; Casts, Surgical; Double-Blind Method; Female; Fractu | 2002 |
Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.
Topics: Achilles Tendon; Adult; Anticoagulants; Braces; Casts, Surgical; Double-Blind Method; Female; Fractu | 2002 |
Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.
Topics: Achilles Tendon; Adult; Anticoagulants; Braces; Casts, Surgical; Double-Blind Method; Female; Fractu | 2002 |
Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.
Topics: Achilles Tendon; Adult; Anticoagulants; Braces; Casts, Surgical; Double-Blind Method; Female; Fractu | 2002 |
[Prospective randomized pilot study of ambulatory prevention of thromboembolism. 2 times 500 mg aspirin (ASS) vs. clivarin 1750 (NMH)].
Topics: Adult; Aged; Ambulatory Care; Anticoagulants; Aspirin; Casts, Surgical; Dose-Response Relationship, | 1998 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures.
Topics: Adult; Aged; Ankle Fractures; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fibula; Fract | 2015 |
Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial.
Topics: Adult; Aged; Ankle Injuries; Anticoagulants; Dalteparin; Double-Blind Method; Female; Fractures, Bon | 2009 |
8 other studies available for dalteparin and Injuries, Leg
| Article | Year |
|---|---|
Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Female; Fibri | 2000 |
Medicine wastage in a thromboprophylaxis protocol for ambulatory trauma patients.
Topics: Anticoagulants; Casts, Surgical; Cost Savings; Emergency Service, Hospital; England; Enoxaparin; Fra | 2020 |
Incidence of deep venous thrombosis after temporary joint spanning external fixation for complex lower extremity injuries.
Topics: Adult; Anticoagulants; Clinical Protocols; Enoxaparin; External Fixators; Female; Fibula; Fracture F | 2009 |
Reviparin after leg injury requiring immobilization.
Topics: Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Immobilization; Leg Injuries; Research Design | 2003 |
Reviparin after leg injury requiring immobilization.
Topics: Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Immobilization; Leg Injuries; Postoperative C | 2003 |
Reviparin after leg injury requiring immobilization.
Topics: Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Immobilization; Incidence; Leg Injuries; Risk | 2003 |
The cost of outpatient venous thromboembolism prophylaxis following lower limb injuries.
Topics: Ambulatory Care; Anticoagulants; Dalteparin; Fracture Fixation; Health Care Costs; Humans; Leg Injur | 2013 |
Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture.
Topics: Anticoagulants; Dalteparin; Female; Fractures, Bone; Humans; Leg Injuries; Male; Venous Thromboembol | 2016 |